Aditya Bardia

Aditya Bardia

UNVERIFIED PROFILE

Are you Aditya Bardia?   Register this Author

Register author
Aditya Bardia

Aditya Bardia

Publications by authors named "Aditya Bardia"

Are you Aditya Bardia?   Register this Author

100Publications

2457Reads

10Profile Views

Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear.

Oncologist 2019 Sep 6. Epub 2019 Sep 6.

Department of Pediatrics, Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0365DOI Listing
September 2019

EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer.

Future Oncol 2019 Aug 20. Epub 2019 Aug 20.

UT Health San Antonio MD Anderson Cancer Center, Division of Hematology/Oncology 7979 Wurzbach Road, San Antonio, TX 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0370DOI Listing
August 2019

Clinical Validation of a Cell-Free DNA Gene Panel.

J Mol Diagn 2019 Jul 23;21(4):632-645. Epub 2019 Apr 23.

Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2019.02.008DOI Listing
July 2019

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.

N Engl J Med 2019 07 4;381(4):307-316. Epub 2019 Jun 4.

From Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine (S.-A.I.), the Yonsei Cancer Center, Yonsei University Health System (J.S.), and the Asan Medical Center, University of Ulsan College of Medicine (K.-H.J.), Seoul, and the Center for Breast Cancer, National Cancer Center, Gyeonggi-do (K.-S.L.) - all in South Korea; National Taiwan University Hospital, Taipei, Taiwan (Y.-S.L.); Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (A.B.); the Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, Munich, Germany (N.H.); the Division of Medical Senology, Istituto Europeo di Oncologia, Milan (M.C.); Hospital de Caridade de Ijuí, CACON, Ijuí, Brazil (F.F.); the Organisation for Oncology and Translational Research, Hong Kong (L.C.); Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico (S.C.-G.); Institut Català d'Oncologia, Hospital de Sant Joan Despí Moisès Broggi, Barcelona (R.V.-V.); Novartis Pharmaceuticals, East Hanover, NJ (A.C., K.R.-L., T.T.); Novartis, Basel, Switzerland (G.H., I.G.); the UCLA Jonsson Comprehensive Cancer Center, Los Angeles (S.H.); and the University of Texas M.D. Anderson Cancer Center, Houston (D.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1903765DOI Listing
July 2019

Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer.

Breast Cancer Res Treat 2019 Jun 27;175(3):649-658. Epub 2019 Mar 27.

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-019-05206-y
Publisher Site
http://dx.doi.org/10.1007/s10549-019-05206-yDOI Listing
June 2019

Genetics to epigenetics: targeting histone deacetylases in hormone receptor-positive metastatic breast cancer.

Lancet Oncol 2019 Jun 27;20(6):746-748. Epub 2019 Apr 27.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30279-7DOI Listing
June 2019

Sacituzumab Govitecan-hziy in Triple-Negative Breast Cancer. Reply.

N Engl J Med 2019 06;380(24):2382

New York-Presbyterian-Columbia University Irving Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1903943DOI Listing
June 2019

Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?

Expert Opin Investig Drugs 2019 Feb 17;28(2):107-112. Epub 2018 Dec 17.

b Massachusetts General Hospital Cancer Center , Harvard Medical School , Boston , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2019.1555239DOI Listing
February 2019

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

N Engl J Med 2019 02;380(8):741-751

From the Massachusetts General Hospital Cancer Center (A.B., S.J.I.) and Dana-Farber Cancer Institute (S.M.T.), Harvard Medical School, Boston; Vanderbilt-Ingram Cancer Center, Nashville (I.A.M., V.G.A.); Weill Cornell Medical College (L.T.V.) and New York-Presbyterian-Columbia University Irving Medical Center (K.K.), New York; University of Colorado Cancer Center, Aurora (J.R.D.); Texas Oncology, Baylor University Medical Center, US Oncology, Dallas (J.O.); Orlando Health University of Florida Health Cancer Center, Orlando (R.L.M., N.C.S.); Yale University School of Medicine, New Haven, CT (A.D.S.); University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.); Immunomedics, Morris Plains, NJ (D.M.G., R.I., S.W., R.M.S., W.A.W.); and AIS Consulting, Ann Arbor, MI (A.M.S.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1814213
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1814213DOI Listing
February 2019

CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions.

Curr Oncol Rep 2019 Feb 26;21(3):25. Epub 2019 Feb 26.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Lawrence House 304, 10 North Grove St, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-019-0769-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6573012PMC
February 2019

Targeted Therapy for Premenopausal Women with HR, HER2 Advanced Breast Cancer: Focus on Special Considerations and Latest Advances.

Clin Cancer Res 2018 11 8;24(21):5206-5218. Epub 2018 Jun 8.

UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0162DOI Listing
November 2018

Case 35-2018: A 68-Year-Old Woman with Back Pain and a Remote History of Breast Cancer.

N Engl J Med 2018 Nov;379(20):1946-1953

From the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Massachusetts General Hospital, and the Departments of Medicine (A.B.), Radiology (M.D.H.), and Pathology (E.F.B., V.N.), Harvard Medical School - both in Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcpc1616400DOI Listing
November 2018

Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing.

J Clin Oncol 2018 Oct 19:JCO1800328. Epub 2018 Oct 19.

Thomas P. Slavin, Kar Wing Kevin Tsang, Susan L. Neuhausen, Stacy W. Gray, and Jeffrey N. Weitzel, City of Hope, Duarte; Kimberly C. Banks, Darya Chudova, Justin I. Odegaard, Rebecca J. Nagy, Christine E. Lee, and Richard B. Lanman, Guardant Health, Redwood City; Razelle Kurzrock, University of California, San Diego, Moores Cancer Center, San Diego, CA; Geoffrey R. Oxnard, Dana-Farber Cancer Institute; Aditya Bardia, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA; Massimo Cristofanilli, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Angel A. Rodriguez, Houston Methodist Hospital; Funda Meric-Bernstam, The University of Texas MD Anderson Cancer Center, Houston, TX; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mike F. Janicek, Arizona Oncology Associates Gynecology Oncology, Scottsdale, AZ; Michael Lilly, Medical University of South Carolina, Charleston, SC; and Guru Sonpavde, The University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00328
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00328DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286162PMC
October 2018

Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial.

J Clin Oncol 2018 Sep 20:JCO2017748392. Epub 2018 Sep 20.

Aditya Bardia, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; Scott Cameron and Serena Liao, Novartis Institutes for BioMedical Research, Cambridge, MA; Marina Parton, The Royal Marsden Hospital, London, United Kingdom; Sherko Kümmel, Kliniken Essen-Mitte, Essen, Germany; Laura G. Estévez, Centro Integral Oncológico Clara Campal; Javier Cortés, University Hospital Ramón y Cajal, Madrid; Javier Cortés,Vall d'Hebron Institute of Oncology, Barcelona; Manuel Ruiz-Borrego, Hospital Universitario Virgen del Rocío, Seville; Paloma Martin-Martorell, Hospital Clínico Universitario de Valencia, Valencia; Rafael López, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain; Chiun-Sheng Huang, National Taiwan University Hospital, National Taiwan University College of Medicine; Shin-Cheh Chen, Chang Gung Memorial Hospital, Taipei, Republic of China; Melinda L. Telli, Stanford University School of Medicine, Stanford; Sara A. Hurvitz, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA; J. Thaddeus Beck, Highlands Oncology Group, Fayetteville, AR; Roohi Ismail-Khan, Moffitt Cancer Center, Tampa, FL; Ingrid A. Mayer, Vanderbilt-Ingram Cancer Center, Nashville, TN; Daniel Carreon, Novartis Pharmaceuticals Corporation, East Hanover, NJ; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.8392
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.8392DOI Listing
September 2018

Cycling Toward Progress: Ribociclib, a CDK 4/6 Inhibitor for Breast Cancer.

Clin Cancer Res 2018 07 23;24(13):2981-2983. Epub 2018 Apr 23.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0463DOI Listing
July 2018

Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments.

Target Oncol 2017 Dec;12(6):719-739

Massachusetts General Hospital Cancer Center, Harvard Medical School, Lawrence House 304, 10 North Grove St., Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-017-0535-0DOI Listing
December 2017

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology.

Oncotarget 2017 Dec 21;8(63):106167-106168. Epub 2017 Nov 21.

Aditya Bardia: Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22580DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739720PMC
December 2017

Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer.

Expert Rev Clin Pharmacol 2017 Nov 18;10(11):1169-1176. Epub 2017 Sep 18.

b Department of Oncology , Massachusetts General Hospital, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2017.1376653DOI Listing
November 2017

Mechanism of Action and Clinical Impact of Ribociclib-Response.

Clin Cancer Res 2017 09;23(18):5658

The Broad Institute and Dana-Farber Cancer Institute, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1819DOI Listing
September 2017

Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan.

J Clin Oncol 2017 Aug 26;35(24):2790-2797. Epub 2017 May 26.

Rebecca Suk Heist and Aditya Bardia, Massachusetts General Hospital Cancer Center; Rebecca Suk Heist and Aditya Bardia, Harvard Medical School, Boston, MA; Michael J. Guarino and Gregory Masters, Helen F. Graham Cancer Center & Research Institute, Newark, DE; W. Thomas Purcell, Wells A. Messersmith, and D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO; Alexander N. Starodub, Indiana University Health Center for Cancer Care, Goshen, IN; Leora Horn and Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN; Ronald J. Scheff and Allyson J. Ocean, Weill Cornell Medicine, New York, NY; and Serengulam V. Govindan, Pius Maliakal, Boyd Mudenda, William A. Wegener, Robert M. Sharkey, and David M. Goldenberg, Immunomedics, Morris Plains, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.1894DOI Listing
August 2017

AKT1 quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer.

Breast Cancer Res 2017 Aug 1;19(1):88. Epub 2017 Aug 1.

Massachusetts General Hospital Cancer Center, Richard B. Simches Research Building, 185 Cambridge Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-017-0877-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540189PMC
August 2017

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2017 Jul 14;35(19):2141-2148. Epub 2017 Mar 14.

Aditya Bardia, Steven J. Isakoff, and Dejan Juric, Massachusetts General Hospital Cancer Center; Aditya Bardia, Steven J. Isakoff, Dejan Juric, and Sara M. Tolaney, Harvard Medical School; Sara M. Tolaney, Dana-Farber Cancer Institute, Boston, MA; Ingrid A. Mayer, Vandana Abramson, and Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN; Jennifer R. Diamond and Wells A. Messersmith, University of Colorado Cancer Center, Aurora, CO; Rebecca L. Moroose and Nikita C. Shah, University of Florida Health Cancer Center, Orlando, FL; Alexander N. Starodub, Indiana University Health Center for Cancer Care, Goshen, IN; Joyce O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center; Joyce O'Shaughnessy, US Oncology, Dallas, TX; Kevin Kalinsky, Columbia University Herbert Irving Comprehensive Cancer Center; Allyson J. Ocean and Linda T. Vahdat, Weill Cornell Medicine, New York, NY; Michael Guarino, Helen F. Graham Cancer Center, Newark, DE; William A. Wegener, Pius Maliakal, Robert M. Sharkey, Serengulam V. Govindan, and David M. Goldenberg, Immunomedics, Morris Plains, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.8297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559902PMC
July 2017

SWISH-ing steroids: new standard of care to prevent everolimus-induced oral mucositis?

Lancet Oncol 2017 05 15;18(5):564-565. Epub 2017 Mar 15.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30106-7DOI Listing
May 2017

Antibody-drug conjugates in breast cancer.

Authors:
Aditya Bardia

Clin Adv Hematol Oncol 2017 Apr;15(4):251-254

Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
April 2017

Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI).

Biomed Opt Express 2017 Feb 4;8(2):555-569. Epub 2017 Jan 4.

Optics Division, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA 02129, USA; Department of Radiology, Harvard Medical School, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1364/BOE.8.000555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330555PMC
February 2017

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.

J Clin Oncol 2015 Nov 14;33(31):3621-7. Epub 2015 Sep 14.

Tanya Keenan, Beverly Moy, Kenneth Ross, Andrzej Niemierko, Steven Isakoff, Leif W. Ellisen, and Aditya Bardia, Massachusetts General Hospital, Harvard Medical School, Boston, MA; and Edmund A. Mroz and James W. Rocco, Ohio State University/Wexner Medical Center and James Cancer Center, Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.2126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979243PMC
November 2015

Gene-Expression-Based Predictors for Breast Cancer.

Ann Surg Oncol 2015 Oct 28;22(11):3418-32. Epub 2015 Jul 28.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4703-0DOI Listing
October 2015

A microfluidic device for label-free, physical capture of circulating tumor cell clusters.

Nat Methods 2015 Jul 18;12(7):685-91. Epub 2015 May 18.

1] Center for Engineering in Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nmeth.3404DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490017PMC
July 2015

Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells.

Adv Mater 2015 Mar 15;27(9):1593-9. Epub 2015 Jan 15.

Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Building 114, 16th Street, Charlestown, MA, 02129, USA; Shriners Hospital for Children, Harvard Medical School, 51 Blossom Street, Boston, MA, 02114, USA; Department of Surgery, Massachusetts General Hospital, Harvard Medical School 55, 55 Fruit Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/adma.201404677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492283PMC
March 2015

Solidifying liquid biopsies: can circulating tumor cell monitoring guide treatment selection in breast cancer?

J Clin Oncol 2014 Nov 14;32(31):3470-1. Epub 2014 Jul 14.

Massachusetts General Hospital Cancer Center; Harvard Medical School, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.1505DOI Listing
November 2014

Precision medicine and personalized breast cancer: combination pertuzumab therapy.

Pharmgenomics Pers Med 2014 20;7:95-105. Epub 2014 Mar 20.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/PGPM.S37100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977457PMC
June 2014

Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system.

Biomed Opt Express 2013 22;4(12):2911-24. Epub 2013 Nov 22.

Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA ; Department of Medicine, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1364/BOE.4.002911DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862147PMC
January 2014

Neoadjuvant therapy as a platform for drug development and approval in breast cancer.

Clin Cancer Res 2013 Dec;19(23):6360-70

Authors' Affiliations: Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; and Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0916DOI Listing
December 2013

Trastuzumab for small HER-2+ breast cancer: small tumor, big decision.

Oncologist 2012 4;17(4):508-11. Epub 2012 Apr 4.

The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336832PMC
October 2012

Personalizing cardiovascular disease prevention among breast cancer survivors.

Curr Opin Cardiol 2012 Sep;27(5):515-24

Department of medicine, Creighton University, Omaha, Nebraska, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-cardiology/2012/09000/Person
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/HCO.0b013e3283570040DOI Listing
September 2012

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer.

Breast Cancer Res Treat 2012 Feb 1;131(3):907-14. Epub 2011 Nov 1.

Breast Cancer Program, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Bunting-Blaustein Cancer Research Building 1, Room 144, 1650 Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1843-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582017PMC
February 2012

Antiemetics for chemotherapy-induced nausea and vomiting occurring despite prophylactic antiemetic therapy.

J Palliat Med 2011 Jul 9;14(7):810-4. Epub 2011 May 9.

Department of Health Sciences Research, Mayo Clinic , Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2011.0058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118930PMC
July 2011

Spinal intradural extraosseous Ewing's sarcoma.

Rare Tumors 2011 Mar 30;3(1):e7. Epub 2011 Mar 30.

Department of Neurology, Johns Hopkins Hospital, Baltimore, MD;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/rt.2011.e7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070450PMC
March 2011

Personalized tamoxifen: a step closer but miles to go.

Clin Cancer Res 2010 Sep 22;16(17):4308-10. Epub 2010 Jul 22.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980759PMC
September 2010

Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy.

Breast Cancer Res Treat 2010 Apr 17;120(2):437-9. Epub 2010 Feb 17.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, 1650 Orleans Street, CRBI, Room 186, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0787-1DOI Listing
April 2010

Anti-inflammatory drugs, antioxidants, and prostate cancer prevention.

Curr Opin Pharmacol 2009 Aug 1;9(4):419-26. Epub 2009 Jul 1.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coph.2009.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479123PMC
August 2009

66-year-old woman with painless vesicular lesions.

Mayo Clin Proc 2009 Jul;84(7):639-42

Division of Primary Care Internal Medicine, Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0025-6196(11)60753-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704136PMC
July 2009

Relative weight at age 12 and risk of postmenopausal breast cancer.

Cancer Epidemiol Biomarkers Prev 2008 Feb 4;17(2):374-8. Epub 2008 Feb 4.

Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-07-0389DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575770PMC
February 2008

Levetiracetam for the treatment of hot flashes: a phase II study.

Support Care Cancer 2008 Jan 28;16(1):75-82. Epub 2007 Jun 28.

Division of Medical Oncology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-007-0276-1DOI Listing
January 2008

Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis.

Mayo Clin Proc 2008 Jan;83(1):23-34

Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/83.1.23DOI Listing
January 2008

Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials.

J Support Oncol 2008 Jan;6(1):27-32

Hematology/Oncology Division, Creighton University Medical Center, Omaha, NE 68132-2867, USA.

View Article

Download full-text PDF

Source
January 2008

Publication bias for CAM trials in the highest impact factor medicine journals is partly due to geographical bias.

J Clin Epidemiol 2007 Nov 10;60(11):1123-6. Epub 2007 May 10.

Division of General Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2007.01.009DOI Listing
November 2007

Diagnosis of obesity by primary care physicians and impact on obesity management.

Mayo Clin Proc 2007 Aug;82(8):927-32

Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002561961161333
Publisher Site
http://dx.doi.org/10.4065/82.8.927DOI Listing
August 2007

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.

J Natl Cancer Inst 2007 Jun;99(11):881-9

Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djk200DOI Listing
June 2007

Dietary supplement usage by patients with cancer undergoing chemotherapy: does prognosis or cancer symptoms predict usage?

J Support Oncol 2007 Apr;5(4):195-8

Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street S.W, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
April 2007

Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.

Arch Intern Med 2006 Dec 11-25;166(22):2478-83

Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.166.22.2478DOI Listing
January 2007

Treatment of obesity.

Mayo Clin Proc 2007 Jan;82(1):93-101; quiz 101-2

Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic College of Medicne, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/82.1.93DOI Listing
January 2007